Previous 10 | Next 10 |
Presentation and Q&A breakout to be webcast on January 13, 2020 beginning at 2:30 p.m. Pacific Time Several clinical milestones expected in RSV, HBV, and NASH/PBC programs in 2020 New discovery program in human metapneumovirus (hMPV) Strong balance sheet and royalty ...
Presentation and Question and Answer Session to be Webcast beginning at 2:30 p.m. PT on January 13, 2020 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today anno...
Enanta Pharmaceuticals (NASDAQ: ENTA ) cut by JMP Securities analyst Liisa Bayko to market perform from market outperform after the company turned in weaker-than-expected fiscal Q4 results. More news on: Enanta Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, ...
Enanta Pharmaceuticals ' (NASDAQ: ENTA) got off to a great start in 2019 with its shares soaring more than 40%. It's been downhill since the first quarter, though. The pharma stock is now down more than 10% year to date. Any hopes that Enanta's fiscal 2019 fourth-quarter results would help t...
Enanta Pharmaceuticals, Inc. (ENTA) Q4 2019 Earnings Conference Call November 21, 2019, 04:30 PM ET Company Participants Carol Miceli - Director, IR Jay Luly - President and CEO Paul Mellett - CFO Nathalie Adda - SVP and Chief Medical Officer Conference Call Participants ...
Image source: The Motley Fool. Enanta Pharmaceuticals Inc (NASDAQ: ENTA) Q4 2019 Earnings Call Nov 21, 2019 , 4:30 p.m. ET Operator Continue reading
Enanta Pharma (NASDAQ: ENTA ): Q4 GAAP EPS of $0.44 misses by $0.12 . More news on: Enanta Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Webcast and Conference Call today at 4:30 p.m. ET Initiation of RSVP, a Phase 2b study of EDP-938 in adult outpatients with RSV EDP-297 selected as follow-on FXR agonist with differentiated preclinical profile Royalty revenue for the quarter was $51.3 million Cash a...
ENTA , GPS , INTU , JWN , MATW , POST , PSTG , ROST , SCVL , SPLK , WSM For Seeking Alpha's full earnings season calendar, click here . More news on: Enanta Pharmaceuticals, Inc., The Gap, Inc., Intuit Inc., Earnings news and commentary,
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced that three preclinical posters on EDP-305, Enanta’s lead Farnesoid X receptor (FXR) agonist, will be presente...
News, Short Squeeze, Breakout and More Instantly...
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
NASDAQ Market:
Enanta Pharmaceuticals Inc. Website:
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strate...
2024-05-10 16:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Nuwellis Inc. (NUWE) rose 60.3% to $0.2741 on volume of 66,284,094 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 21.1% to $0.05 on volume of 64,247,106 shares Clearmind Medicine Inc. (CMND) rose 37.6% to $1.61 on volume ...